Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Company details
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) designs, optimizes and develops novel drugs that block key enzymes essential for viral, cardiovascular and oncologic disease processes.The company in detail
Summary
BioCryst was founded in 1986. BioCryst Pharmaceuticals has a streamlined corporate infrastructure focusing exclusively on its strongest areas of expertise: enzyme-based drug discovery, structure-based drug design and early stage clinical development of small molecule pharmaceuticals. Strategic alliances with business, clinical development and regulatory experts complement the company's internal capabilities. The company uses strategic alliances early in the drug identification process, through the aggressive in-licensing of drug targets, and in late stage clinical development, with large pharmaceutical or biotechnology companies that have expertise in BioCryst's therapeutic areas of focus.
R&D
To view this information, you must subscribe to Partneringtools.
Partnerships
To view this information, you must subscribe to Partneringtools.
Deals
To view this information, you must subscribe to Partneringtools.
Senior management
To view this information, you must subscribe to Partneringtools.
Board of directors
To view this information, you must subscribe to Partneringtools.
Head office
To view this information, you must subscribe to Partneringtools.
Related companies
Related categories
- Industry sector
- Biotechnology / Human therapeutics
- Drug discovery
- Pharmaceutical / Prescription
- Therapeutic target
- Cardiovascular
- Cardiovascular / Acute coronary syndromes
- Cardiovascular / Thrombotic disorders / Thrombosis
- Cardiovascular / Acute coronary syndromes / Angina
- Dermatological
- Immune related disorders
- Immune related disorders / Autoimmune disease (non-specific)
- Immune related disorders / Immune disorder (non-specific)
- Immune related disorders / Servere combined immunodeficency
- Infectious diseases
- Infectious diseases / Diseases / Hepatitis C/D/E
- Infectious diseases / Diseases / Infection, viral (other)
- Musculoskeletal
- Musculoskeletal / Skeletal / Arthritis (non-specific)
- Musculoskeletal / Skeletal / Rheumatoid arthritis
- Musculoskeletal / Skeletal / Rheumatic disorders (other)
- Oncology
- Respiratory
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us